查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824618

2025年临床次世代定序（NGS）资料分析全球市场报告

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

临床新一代定序 (NGS) 数据分析市场预计将在未来几年内快速成长，到 2029 年将达到 82.4 亿美元，复合年增长率为 18.8%。预测期内的成长可归因于液态切片技术的日益普及、人工智慧在数据分析中的整合、精准医疗计划的扩展、新型定序技术的出现以及对群体基因组学计划的日益关注。预测期内的主要趋势包括伴随诊断的成长、分散式检查模式的兴起、云端基础解决方案的使用日益增多、NGS 在非侵入性产前检测中的应用不断扩展以及资料解读标准化通讯协定的发展。

我们预测未来五年该市场将成长18.8%，较我们先前对该市场的预测略有下降0.8%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的基因组医学，因为这会增加从芬兰和丹麦进口的美国云端基础资讯平台和变异解读软体的成本，从而可能减缓精准肿瘤学的普及并提高分析成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税的影响可能更为广泛。

临床新一代定序数据分析市场预计将在个人化医疗需求不断增长的推动下实现成长。个人化医疗根据个人的基因、环境和生活方式因素量身定制，由于基因组技术的进步、疾病复杂性的增加、治疗效果的改善以及医疗成本的上升，正日益受到关注。次世代定序(NGS) 资料分析在个人化医疗中发挥关键作用，有助于快速且准确地对多个基因定序，从而更好地了解个体的基因图谱。例如，2022 年 10 月的数据显示，基因检测产品和个人化医疗数量显着增加，其中个人化医疗在新药认证中占比显着，凸显了 NGS 数据分析在推动个人化医疗应用方面发挥的重要作用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球临床次世代定序 (NGS) 资料分析：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球临床次世代定序 (NGS) 数据分析市场：成长率分析
  • 全球临床次世代定序 (NGS) 资料分析市场表现：规模与成长，2019-2024 年
  • 全球临床次世代定序 (NGS) 资料分析市场预测：规模与成长，2024-2029 年，2034 年
  • 全球临床次世代定序 (NGS) 资料分析：总目标市场 (TAM)

第六章 市场细分

  • 全球临床次世代定序 (NGS) 资料分析市场（按解决方案和服务、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • NGS资料分析工具
  • NGS资料分析与定序服务
  • NGS储存、管理与云端运算平台
  • 平台
  • 全球临床次世代定序 (NGS) 资料分析市场（按技术、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 边合成边定定序（SBS）
  • 奈米孔定序
  • 单分子即时（SMRT）定序
  • 其他技术
  • 全球临床次世代定序 (NGS) 资料分析市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断
  • 药物发现与设计
  • 医学研究
  • 其他用途
  • 全球临床次世代定序 (NGS) 资料分析市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 学术机构与研究中心
  • 生技公司
  • 生命科学技术供应商
  • 其他最终用户
  • 全球临床次世代定序 (NGS) 资料分析市场：按 NGS 资料分析工具细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 软体平台
  • 数据解释工具
  • 生物资讯学工具
  • 数据分析解决方案
  • 全球临床次世代定序 (NGS) 资料分析市场：细分 NGS 资料分析和定序服务（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 定序服务
  • 数据分析服务
  • 咨询服务
  • 研究和诊断服务
  • 全球临床次世代定序 (NGS) 资料分析市场：按 NGS 储存、管理和云端运算平台（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 资料储存解决方案
  • 资料管理平台
  • 云端基础的平台
  • 云端储存服务
  • 全球临床次世代定序 (NGS) 资料分析市场：按平台（类型）细分、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 定序平台
  • NGS仪器平台
  • 整合NGS平台

第七章 区域和国家分析

  • 全球临床次世代定序 (NGS) 资料分析市场：区域分析、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球临床次世代定序 (NGS) 资料分析市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 临床次世代定序 (NGS) 资料分析市场：竞争格局
  • 临床次世代定序（NGS）资料分析市场：公司简介
    • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen
  • BGI Group
  • 10x Genomics
  • Genomic Health
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc.
  • Sophia Genetics
  • Genewiz
  • Partek Inc.
  • DNAnexus
  • BioNano Genomics
  • PierianDx
  • GENAPSYS

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年临床次世代定序（NGS）资料分析市场：提供新机会的国家
  • 2029年临床次世代定序（NGS）资料分析市场：细分市场带来新机会
  • 2029年临床下一代定序（NGS）资料分析市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27676u

Clinical next-generation sequencing (NGS) data analysis is the interpretation of genetic information acquired through advanced sequencing technologies within a clinical context. These technologies enable the rapid and cost-effective sequencing of large DNA or RNA samples, allowing for the identification of genetic variations associated with diseases or conditions. This analytical process is essential for comprehending the genetic underpinnings of diseases, supporting personalized medicine approaches, and guiding clinical decision-making.

The main types of solutions and services in clinical next-generation sequencing (NGS) data analysis encompass NGS data analysis tools, NGS data analysis and sequencing services, and NGS storage, management, and cloud computing platforms. NGS data analysis tools are software applications designed to interpret and process the vast amount of data generated through NGS technologies. Leveraging various sequencing technologies such as sequencing by synthesis (SBS), nanopore sequencing, and single-molecule real-time (SMRT) sequencing, these tools find applications in diagnostics, drug discovery, medical research, and other domains. End-users of these tools span hospitals, clinics, academic institutes, research centers, biotechnology companies, and life science technology vendors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical next-generation sequencing (NGS) data analysis market research report is one of a series of new reports from The Business Research Company that provides clinical next-generation sequencing (NGS) data analysis market statistics, including clinical next-generation sequencing (NGS) data analysis industry global market size, regional shares, competitors with a clinical next-generation sequencing (NGS) data analysis market share, detailed clinical next-generation sequencing (NGS) data analysis market segments, market trends and opportunities, and any further data you may need to thrive in the clinical next-generation sequencing (NGS) data analysis industry. This clinical next-generation sequencing (NGS) data analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical next-generation sequencing (ngs) data analysis market size has grown exponentially in recent years. It will grow from $3.43 billion in 2024 to $4.14 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to research advancements in genomics, declining sequencing costs, growing demand for personalized medicine, expanding applications in clinical diagnostics, increasing prevalence of genetic diseases.

The clinical next-generation sequencing (ngs) data analysis market size is expected to see rapid growth in the next few years. It will grow to $8.24 billion in 2029 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to rising adoption of liquid biopsy techniques, integration of artificial intelligence in data analysis, expansion of precision medicine initiatives, emergence of novel sequencing technologies, increasing focus on population genomics initiatives. Major trends in the forecast period include growth of companion diagnostics, rise of decentralized testing models, increasing use of cloud-based solutions, expansion of NGS applications in non-invasive prenatal testing, development of standardized protocols for data interpretation.

The forecast of 18.8% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. genomic medicine by increasing costs for cloud-based bioinformatics platforms and variant interpretation software imported from Finland and Denmark, potentially slowing precision oncology implementation and raising analysis costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The clinical next-generation sequencing data analysis market is poised for growth, propelled by the rising demand for personalized medicines. Personalized medicine, tailored to individual genetic, environmental, and lifestyle factors, gains prominence due to genomic technologies, increasing disease complexity, improved treatment outcomes, and escalating healthcare costs. Next-generation sequencing (NGS) data analysis plays a pivotal role in personalized medicine, facilitating rapid and accurate sequencing of multiple genes, thereby enhancing understanding of an individual's genetic profile. For example, data from October 2022 reports a significant number of genetic testing products and personalized medicines, with personalized medicines accounting for a notable portion of new drug approvals, underlining the integral role of NGS data analysis in driving personalized medicine adoption.

Key players in the clinical NGS data analysis market are innovating to meet burgeoning demands for genomic analysis accuracy. Advanced solutions such as the NextSeq 2000 Sequencing System represent significant developments in this realm. This system comprises integrated hardware and software components designed to streamline DNA sequencing processes, offering precise nucleotide sequencing within DNA molecules. For instance, Illumina Inc.'s September 2022 launch of the NovaSeq X Series introduces a paradigm shift in production-scale sequencing, boasting enhanced speed, power, and sustainability. Leveraging innovative technology such as XLEAP-SBS chemistry and ultra-high density flow cells, the NovaSeq X Series offers substantially increased throughput and sequencing accuracy, meeting the escalating demands for genomic analysis.

In January 2023, QIAGEN NV, a Germany-based provider of molecular testing solutions, acquired Verogen Inc. for $150 million. The acquisition aims to strengthen QIAGEN's molecular testing and forensic genomics offerings by incorporating Verogen's next-generation sequencing (NGS) technology, which enhances capabilities in genetic analysis. Verogen Inc., a US-based company, specializes in NGS solutions focused on human identification (Human ID) and forensic applications.

Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.

North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical next-generation sequencing (NGS) data analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical next-generation sequencing data analysis market consists of revenues earned by entities by providing services such as data preprocessing, alignment, variable calling, annotation, prioritization, interpretation, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical next-generation sequencing data analysis market also includes sales of software tools, platforms, and pre-processing tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical next-generation sequencing (ngs) data analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical next-generation sequencing (ngs) data analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical next-generation sequencing (ngs) data analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Solution And Services: NGS Data Analysis Tools; NGS Data Analysis And Sequencing Services; NGS Storage, Management And Cloud Computing Platform; Platforms
  • 2) By Technology: Sequencing By Synthesis (SBS); Nanopore Sequencing; Single-Molecule Real-Time (SMRT) Sequencing; Other Technologies
  • 3) By Application: Diagnostics; Drug Discovery And Designing; Medical Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Academic Institutes And Research Centers; Biotechnology Companies; Life Science Technology Vendors; Other End Users
  • Subsegments:
  • 1) By NGS Data Analysis Tools: Software Platforms; Data Interpretation Tools; Bioinformatics Tools; Data Analytics Solutions
  • 2) By NGS Data Analysis And Sequencing Services: Sequencing Services; Data Analysis Services; Consultation Services; Research And Diagnostic Services
  • 3) By NGS Storage, Management, And Cloud Computing Platform: Data Storage Solutions; Data Management Platforms; Cloud-Based Platforms; Cloud Storage Services
  • 4) By Platforms: Sequencing Platforms; NGS Instrumentation Platforms; Integrated NGS Platforms
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen; BGI Group; 10x Genomics; Genomic Health; Oxford Nanopore Technologies PLC.; Pacific Biosciences of California Inc.; Sophia Genetics; Genewiz; Partek Inc.; DNAnexus; BioNano Genomics; PierianDx; GENAPSYS; Nugen Technologies; DNAStar Inc.; Swift Biosciences; Basepair; BioDatomics; Congenica Ltd.; Theragen Etex Inc.; Golden Helix Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Characteristics

3. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends And Strategies

4. Clinical Next-Generation Sequencing (NGS) Data Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Growth Rate Analysis
  • 5.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Total Addressable Market (TAM)

6. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Segmentation

  • 6.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NGS Data Analysis Tools
  • NGS Data Analysis And Sequencing Services
  • NGS Storage, Management And Cloud Computing Platform
  • Platforms
  • 6.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Other Technologies
  • 6.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery And Designing
  • Medical Research
  • Other Applications
  • 6.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Academic Institutes And Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Other End Users
  • 6.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Platforms
  • Data Interpretation Tools
  • Bioinformatics Tools
  • Data Analytics Solutions
  • 6.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis And Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Services
  • Data Analysis Services
  • Consultation Services
  • Research And Diagnostic Services
  • 6.7. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Storage, Management, And Cloud Computing Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Storage Solutions
  • Data Management Platforms
  • Cloud-Based Platforms
  • Cloud Storage Services
  • 6.8. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Platforms
  • NGS Instrumentation Platforms
  • Integrated NGS Platforms

7. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Regional And Country Analysis

  • 7.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 8.1. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 9.1. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 9.2. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 10.1. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 11.1. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 11.2. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 12.1. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 13.1. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 14.1. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 14.2. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 15.1. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 15.2. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 16.1. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 17.1. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 18.1. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 19.1. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 20.1. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 21.1. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 21.2. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 22.1. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 23.1. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 23.2. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 24.1. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 24.2. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 25.1. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 25.2. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 26.1. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 26.2. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 27.1. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 28.1. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 28.2. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 29.1. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 29.2. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape
  • 30.2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Company Profiles
    • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen
  • 31.4. BGI Group
  • 31.5. 10x Genomics
  • 31.6. Genomic Health
  • 31.7. Oxford Nanopore Technologies PLC
  • 31.8. Pacific Biosciences of California Inc.
  • 31.9. Sophia Genetics
  • 31.10. Genewiz
  • 31.11. Partek Inc.
  • 31.12. DNAnexus
  • 31.13. BioNano Genomics
  • 31.14. PierianDx
  • 31.15. GENAPSYS

32. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

34. Recent Developments In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

35. Clinical Next-Generation Sequencing (NGS) Data Analysis Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer